• How to escape a deep drawdown in Protagonist Therapeutics Inc. - Stop Loss & High Accuracy Swing Entry Alerts newser.com Fri, 03 Oct 2025 09:22:39 GMT
• Can Protagonist Therapeutics Inc. stock hit record highs again - Quarterly Profit Summary & Short-Term Trading Alerts newser.com Fri, 03 Oct 2025 09:16:11 GMT
• Why Protagonist Therapeutics Inc. stock could be next big winner - July 2025 Update & Daily Entry Point Alerts newser.com Fri, 03 Oct 2025 08:37:23 GMT
• Sentiment analysis tools applied to Protagonist Therapeutics Inc. - 2025 Earnings Surprises & Fast Moving Market Watchlists newser.com Fri, 03 Oct 2025 06:55:11 GMT
• Short interest data insights for Protagonist Therapeutics Inc. - Earnings Beat & Free Low Drawdown Momentum Trade Ideas newser.com Fri, 03 Oct 2025 04:15:53 GMT
• Protagonist Announces Icotrokinra Phase 2b ANTHEM-UC Trial Data to be Presented at the United European Gastroenterology Week Berli... Democrat and Chronicle Wed, 01 Oct 2025 14:31:38 GMT
• Sentiment analysis tools applied to Protagonist Therapeutics Inc. - 2025 Trading Volume Trends & Daily Stock Trend Watchlist newser.com Wed, 01 Oct 2025 14:15:57 GMT
• Why Protagonist Therapeutics Inc. stock could be next big winner - July 2025 Analyst Calls & Real-Time Volume Spike Alerts newser.com Wed, 01 Oct 2025 12:13:22 GMT
• Can Protagonist Therapeutics Inc. stock hit record highs again - July 2025 Breakouts & AI Optimized Trade Strategies newser.com Wed, 01 Oct 2025 11:50:21 GMT
• short interest data insights for protagonist therapeutics inc. - m&a rumor & high accuracy swing trade signals newser.com Wed, 01 Oct 2025 10:25:21 GMT
• Can Protagonist Therapeutics Inc. stock hit record highs again - Quarterly Performance Summary & Community Verified Watchlist Aler... newser.com Tue, 30 Sep 2025 07:51:03 GMT
• historical volatility pattern of protagonist therapeutics inc. visualized - long setup & real-time buy signal notifications newser.com Tue, 30 Sep 2025 05:04:03 GMT
• protagonist announces icotrokinra phase 2b anthem-uc trial data to be presented at the united european gastroenterology week berli... Sarasota Herald-Tribune Tue, 30 Sep 2025 04:11:37 GMT
• protagonist therapeutics (nasdaq:ptgx) shares down 5.1% - what's next? MarketBeat Mon, 29 Sep 2025 22:23:45 GMT
• Sentiment analysis tools applied to Protagonist Therapeutics Inc. - 2025 Biggest Moves & Community Trade Idea Sharing Platform newser.com Mon, 29 Sep 2025 16:15:47 GMT
• Protagonist Therapeutics Hits New 52-Week High of $68.26, Up 103% Markets Mojo Mon, 29 Sep 2025 14:23:06 GMT
• Why Protagonist Therapeutics Inc. stock could be next big winner - July 2025 PreEarnings & Intraday High Probability Alerts newser.com Mon, 29 Sep 2025 12:00:32 GMT
• Protagonist Therapeutics to Participate in Multiple Investment Bank Conferences in September 2025 Corpus Christi Caller-Times Mon, 29 Sep 2025 11:50:36 GMT
• Can Protagonist Therapeutics Inc. stock hit record highs again - 2025 AllTime Highs & Daily Volume Surge Trade Alerts newser.com Mon, 29 Sep 2025 09:03:32 GMT
• Historical volatility pattern of Protagonist Therapeutics Inc. visualized - 2025 Key Lessons & Consistent Growth Equity Picks newser.com Mon, 29 Sep 2025 07:27:06 GMT
• what analysts say about protagonist therapeutics inc stock - global market influence & free discover massive upside stocks earlytimes.in Sun, 28 Sep 2025 15:18:52 GMT
• Short interest data insights for Protagonist Therapeutics Inc. - Bond Market & Growth-Oriented Investment Plans newser.com Sun, 28 Sep 2025 11:38:23 GMT
• what drives protagonist therapeutics inc stock price - market liquidity analysis & market monitoring and alerts earlytimes.in Sun, 28 Sep 2025 03:35:00 GMT
• Can Protagonist Therapeutics Inc. stock hit record highs again - Portfolio Update Summary & Community Consensus Trade Alerts newser.com Sat, 27 Sep 2025 20:28:49 GMT
• protagonist therapeutics (mex:ptgx) tariff resilience score : 5/10 (as of sep. 27, 2025) GuruFocus Sat, 27 Sep 2025 03:07:16 GMT
• protagonist therapeutics (mex:ptgx) momentum rank : 9 (as of sep. 27, 2025) GuruFocus Sat, 27 Sep 2025 01:57:16 GMT
• Protagonist Therapeutics stock reaches all-time high at 66.7 USD By Investing.com Investing.com Nigeria Fri, 26 Sep 2025 19:25:51 GMT
• Why Protagonist Therapeutics Inc. stock could be next big winner - Market Rally & High Accuracy Trade Signal Alerts newser.com Fri, 26 Sep 2025 17:00:21 GMT
• Protagonist Announces Icotrokinra Phase 2b ANTHEM-UC Trial Data to be Presented at the United European Gastroenterology Week Berli... Lohud Thu, 25 Sep 2025 22:21:38 GMT
• Protagonist Therapeutics Hits New 52-Week High of $66.70, Up 98.82% Markets Mojo Thu, 25 Sep 2025 20:40:43 GMT
• h.c. wainwright maintains protagonist therapeutics(ptgx.us) with buy rating, maintains target price $80 富途牛牛 Thu, 25 Sep 2025 17:59:30 GMT
• waddill, protagonist therapeutics director, sells $257k in shares by investing.com Investing.com South Africa Thu, 25 Sep 2025 10:58:49 GMT
• 7,530 shares in protagonist therapeutics, inc. $ptgx acquired by palumbo wealth management llc MarketBeat Thu, 25 Sep 2025 10:21:41 GMT
• assenagon asset management s.a. increases stock position in protagonist therapeutics, inc. $ptgx MarketBeat Thu, 25 Sep 2025 07:37:27 GMT
• insider sell: william waddill sells 4,000 shares of protagonist therapeutics inc (ptgx) GuruFocus Thu, 25 Sep 2025 03:00:44 GMT
• protagonist therapeutics (nasdaq:ptgx) director sells $257,000.00 in stock MarketBeat Thu, 25 Sep 2025 02:17:07 GMT
• sentiment analysis tools applied to protagonist therapeutics inc. - 2025 market outlook & low drawdown momentum trade ideas newser.com Wed, 24 Sep 2025 17:28:27 GMT
• h.c. wainwright maintains protagonist therapeutics(ptgx.us) with buy rating, maintains target price $80 富途牛牛 Wed, 24 Sep 2025 15:45:34 GMT
• wedbush maintains protagonist therapeutics(ptgx.us) with buy rating, maintains target price $70 富途牛牛 Wed, 24 Sep 2025 15:40:35 GMT
• protagonist therapeutics (nasdaq:ptgx) reaches new 12-month high - should you buy? MarketBeat Wed, 24 Sep 2025 09:41:30 GMT
• protagonist therapeutics hits new 52-week high of $64.59, up 94.48% Markets Mojo Wed, 24 Sep 2025 07:12:45 GMT
• protagonist therapeutics announces presentations of icotrokinra data MSN Wed, 24 Sep 2025 02:47:46 GMT
• Protagonist Announces Presentations of Clinical Data with Icotrokinra in Plaque Psoriasis and Preclinical Data with PN-881 at the ... The Des Moines Register Tue, 23 Sep 2025 19:13:09 GMT
• Protagonist Announces Icotrokinra Phase 2b ANTHEM-UC Trial Data to be Presented at the United European Gastroenterology Week Berli... Detroit Free Press Tue, 23 Sep 2025 18:09:54 GMT
• leerink partners maintains protagonist therapeutics(ptgx.us) with buy rating 富途牛牛 Tue, 23 Sep 2025 15:00:00 GMT
• voya investment management llc has $2.89 million stake in protagonist therapeutics, inc. $ptgx MarketBeat Tue, 23 Sep 2025 07:00:00 GMT
• protagonist therapeutics, inc. $ptgx shares acquired by exchange traded concepts llc MarketBeat Tue, 23 Sep 2025 07:00:00 GMT
• strs ohio takes $919,000 position in protagonist therapeutics, inc. $ptgx MarketBeat Tue, 23 Sep 2025 06:18:54 GMT
• voya investment management llc sells 22,949 shares of protagonist therapeutics, inc. $ptgx MarketBeat Tue, 23 Sep 2025 06:02:54 GMT
• protagonist announces icotrokinra application for approval in plaque psoriasis submitted to the european medicines agency Lubbock Avalanche-Journal Tue, 23 Sep 2025 05:43:33 GMT
• protagonist therapeutics (nasdaq:ptgx) sets new 12-month high - here's why MarketBeat Tue, 23 Sep 2025 05:10:21 GMT
• protagonist therapeutics (nasdaq:ptgx) coverage initiated at barclays MarketBeat Tue, 23 Sep 2025 00:30:58 GMT
• protagonist therapeutics hits new 52-week high of $63.30 Markets Mojo Mon, 22 Sep 2025 22:20:02 GMT
• analysts set protagonist therapeutics, inc. (nasdaq:ptgx) target price at $68.08 MarketBeat Mon, 22 Sep 2025 08:55:10 GMT
• protagonist therapeutics, inc. (nasdaq:ptgx) receives consensus rating of "buy" from analysts MarketBeat Mon, 22 Sep 2025 08:55:10 GMT
• protagonist therapeutics (nasdaq:ptgx) coverage initiated by analysts at barclays MarketBeat Mon, 22 Sep 2025 08:09:38 GMT
• strs ohio takes $919,000 position in protagonist therapeutics, inc. $ptgx MarketBeat Mon, 22 Sep 2025 07:00:00 GMT
• protagonist therapeutics (nasdaq:ptgx) sets new 12-month high - here's why MarketBeat Mon, 22 Sep 2025 07:00:00 GMT
• barclays begins coverage on protagonist therapeutics (nasdaq:ptgx) MarketBeat Mon, 22 Sep 2025 07:00:00 GMT
• protagonist therapeutics (nasdaq:ptgx) reaches new 12-month high - here's what happened MarketBeat Mon, 22 Sep 2025 05:08:03 GMT
• protagonist therapeutics' (ptgx) buy rating reaffirmed at hc wainwright MarketBeat Mon, 22 Sep 2025 04:53:33 GMT
• 19,000 shares in protagonist therapeutics, inc. $ptgx purchased by strs ohio MarketBeat Mon, 22 Sep 2025 01:26:18 GMT
• protagonist announces icotrokinra phase 2b anthem-uc trial data to be presented at the united european gastroenterology week berli... USA Today Mon, 22 Sep 2025 00:49:04 GMT
• exchange traded concepts llc grows holdings in protagonist therapeutics, inc. $ptgx MarketBeat Sun, 21 Sep 2025 12:23:48 GMT
• exchange traded concepts llc has $2.62 million stock position in protagonist therapeutics, inc. $ptgx MarketBeat Sun, 21 Sep 2025 12:23:48 GMT
• exchange traded concepts llc purchases 19,999 shares of protagonist therapeutics, inc. $ptgx MarketBeat Sun, 21 Sep 2025 12:23:48 GMT
• 19,000 shares in protagonist therapeutics, inc. $ptgx acquired by strs ohio MarketBeat Sun, 21 Sep 2025 08:36:55 GMT
• voya investment management llc has $2.89 million stock holdings in protagonist therapeutics, inc. $ptgx MarketBeat Sun, 21 Sep 2025 07:25:39 GMT
• Protagonist Therapeutics (PTGX) Is Up 5.7% After Positive Phase 3 Icotrokinra Results - Has The Bull Case Changed? simplywall.st Sun, 21 Sep 2025 07:00:00 GMT
• protagonist therapeutics' (ptgx) buy rating reaffirmed at hc wainwright MarketBeat Sun, 21 Sep 2025 07:00:00 GMT
• protagonist therapeutics (nasdaq:ptgx) coverage initiated by analysts at barclays MarketBeat Sun, 21 Sep 2025 07:00:00 GMT
• protagonist therapeutics (nasdaq:ptgx) earns "buy" rating from hc wainwright MarketBeat Sun, 21 Sep 2025 00:41:43 GMT
• Protagonist Therapeutics Hits New 52-Week High at $62.21 Markets Mojo Sat, 20 Sep 2025 11:48:15 GMT
• bank watch: can protagonist therapeutics inc be the next market leader - market trend report & ai enhanced trade execution alerts خودرو بانک Sat, 20 Sep 2025 09:41:48 GMT
• protagonist therapeutics (nasdaq:ptgx) hits new 12-month high - time to buy? MarketBeat Fri, 19 Sep 2025 18:46:02 GMT
• protagonist therapeutics (nasdaq:ptgx) reaches new 12-month high - what's next? MarketBeat Fri, 19 Sep 2025 18:46:02 GMT
• protagonist therapeutics (nasdaq:ptgx) now covered by analysts at barclays MarketBeat Fri, 19 Sep 2025 12:03:52 GMT
• protagonist therapeutics (nasdaq:ptgx) earns overweight rating from analysts at barclays MarketBeat Fri, 19 Sep 2025 12:03:52 GMT
• protagonist therapeutics’ icotrokinra: promising efficacy and safety profile justifies buy rating TipRanks Fri, 19 Sep 2025 11:24:12 GMT
• leerink partners maintains protagonist therapeutics(ptgx.us) with buy rating 富途牛牛 Fri, 19 Sep 2025 10:32:00 GMT
• protagonist announces icotrokinra application for approval in plaque psoriasis submitted to the european medicines agency Lohud Fri, 19 Sep 2025 10:31:48 GMT
• protagonist therapeutics, inc. $ptgx shares bought by inspire investing llc MarketBeat Fri, 19 Sep 2025 10:31:11 GMT
• strs ohio makes new investment in protagonist therapeutics, inc. $ptgx MarketBeat Fri, 19 Sep 2025 08:36:45 GMT
• strs ohio invests $919,000 in protagonist therapeutics, inc. $ptgx MarketBeat Fri, 19 Sep 2025 08:36:45 GMT
• wedbush maintains protagonist therapeutics(ptgx.us) with buy rating, maintains target price $70 富途牛牛 Fri, 19 Sep 2025 07:00:00 GMT
• patterns watch: is protagonist therapeutics inc. affected by consumer sentiment - breakout watch & daily profit focused stock scre... خودرو بانک Thu, 18 Sep 2025 21:20:37 GMT
• protagonist therapeutics stock hits all-time high of 61.89 usd by investing.com Investing.com South Africa Thu, 18 Sep 2025 17:01:53 GMT
• protagonist therapeutics (nasdaq:ptgx) given buy rating at hc wainwright MarketBeat Thu, 18 Sep 2025 15:54:18 GMT
• protagonist therapeutics (nasdaq:ptgx) now covered by barclays MarketBeat Thu, 18 Sep 2025 12:18:04 GMT
• volatility watch: is protagonist therapeutics inc. vulnerable to short sellers - 2025 buyback activity & verified chart pattern si... خودرو بانک Thu, 18 Sep 2025 12:10:52 GMT
• inspire investing llc acquires 11,279 shares of protagonist therapeutics, inc. $ptgx MarketBeat Thu, 18 Sep 2025 10:13:31 GMT
• protagonist therapeutics, inc. $ptgx shares bought by inspire investing llc MarketBeat Thu, 18 Sep 2025 07:00:00 GMT
• protagonist therapeutics (nasdaq:ptgx) raised to "strong-buy" at leerink partnrs MarketBeat Thu, 18 Sep 2025 07:00:00 GMT
• h.c. wainwright maintains protagonist therapeutics(ptgx.us) with buy rating, maintains target price $80 富途牛牛 Thu, 18 Sep 2025 07:00:00 GMT
• protagonist therapeutics to participate in multiple investment bank conferences in september 2025 Shreveport Times Thu, 18 Sep 2025 06:22:24 GMT
• buy signal: is protagonist therapeutics inc. stock a good pick for beginners - july 2025 macro moves & real-time volume analysis خودرو بانک Thu, 18 Sep 2025 04:02:11 GMT
• protagonist announces icotrokinra application for approval in plaque psoriasis submitted to the european medicines agency The Courier-Journal Thu, 18 Sep 2025 02:14:02 GMT
• protagonist announces icotrokinra application for approval in plaque psoriasis submitted to the european medicines agency Knoxville News Sentinel Wed, 17 Sep 2025 23:38:48 GMT
• hc wainwright reiterates 'buy' rating for ptgx with $80 target | GuruFocus Wed, 17 Sep 2025 16:59:24 GMT
• protagonist therapeutics, inc. (ptgx): a bull case theory Yahoo Finance Wed, 17 Sep 2025 15:45:35 GMT
• performance recap: can protagonist therapeutics inc. keep up with sector leaders - 2025 performance recap & reliable breakout fore... khodrobank.com Wed, 17 Sep 2025 15:45:08 GMT
• j&j's il-23 drug defeats sotyktu in phase 3 psoriasis trial Fierce Biotech Wed, 17 Sep 2025 13:45:00 GMT
• protagonist therapeutics announces presentations of icotrokinra data TipRanks Wed, 17 Sep 2025 13:30:15 GMT
• today's analyst rating: barclays initiates coverage on ptgx with overweight | ptgx stock news GuruFocus Wed, 17 Sep 2025 12:18:58 GMT
• Barclays Initiates Coverage of Protagonist Therapeutics (PTGX) with Overweight Recommendation Nasdaq Wed, 17 Sep 2025 07:00:00 GMT
• Barclays initiates Protagonist Therapeutics stock with Overweight rating Investing.com Wed, 17 Sep 2025 07:00:00 GMT
• This Protagonist Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday Benzinga Wed, 17 Sep 2025 07:00:00 GMT
• Protagonist Therapeutics (PTGX) Unveils Promising Phase 3 Trial Data for Psoriasis Treatment GuruFocus Wed, 17 Sep 2025 07:00:00 GMT
• 84% Skin Clearance: Protagonist's Oral Psoriasis Drug Outperforms Injectable Treatment in Phase 3 Trial Stock Titan Wed, 17 Sep 2025 07:00:00 GMT
• protagonist announces presentations of clinical data with icotrokinra in plaque psoriasis and preclinical data with pn-881 at the ... The Oklahoman Wed, 17 Sep 2025 07:00:00 GMT
• protagonist therapeutics (nasdaq:ptgx) now covered by analysts at leerink partners MarketBeat Wed, 17 Sep 2025 07:00:00 GMT
• j&j's il-23 drug defeats reigning champ sotyktu in phase 3 psoriasis trial Fierce Biotech Wed, 17 Sep 2025 07:00:00 GMT
• h.c. wainwright maintains protagonist therapeutics(ptgx.us) with buy rating, maintains target price $80 富途牛牛 Wed, 17 Sep 2025 07:00:00 GMT
• johnson & johnson, protagonist study shows superior skin clearance in psoriasis trials Benzinga Wed, 17 Sep 2025 07:00:00 GMT
• focus partners wealth boosts position in protagonist therapeutics, inc. $ptgx MarketBeat Wed, 17 Sep 2025 07:00:00 GMT
• empowered funds llc makes new $4.96 million investment in protagonist therapeutics, inc. $ptgx MarketBeat Wed, 17 Sep 2025 07:00:00 GMT
• fred alger management llc takes $362,000 position in protagonist therapeutics, inc. $ptgx MarketBeat Wed, 17 Sep 2025 03:53:56 GMT
• Protagonist Therapeutics, Inc. Experiences Revision in Stock Evaluation Amid Mixed Market Signals Markets Mojo Wed, 17 Sep 2025 01:12:51 GMT
• empowered funds llc makes new $4.96 million investment in protagonist therapeutics, inc. $ptgx MarketBeat Tue, 16 Sep 2025 23:47:40 GMT
• focus partners wealth purchases 9,540 shares of protagonist therapeutics, inc. $ptgx MarketBeat Tue, 16 Sep 2025 21:05:44 GMT
• forecast cut: is protagonist therapeutics inc forming a bullish divergence - 2025 earnings surprises & daily stock momentum report... خودرو بانک Tue, 16 Sep 2025 19:48:21 GMT
• technical analysis: can protagonist therapeutics inc. stock outperform in a bear market - weekly trading summary & weekly watchlis... خودرو بانک Tue, 16 Sep 2025 18:59:50 GMT
• setup watch: can protagonist therapeutics inc be the next market leader - 2025 fundamental recap & reliable price breakout signals... خودرو بانک Tue, 16 Sep 2025 18:42:28 GMT
• Protagonist Therapeutics initiated with an Overweight at Barclays TipRanks Tue, 16 Sep 2025 07:00:00 GMT
• 7,477 shares in protagonist therapeutics, inc. $ptgx purchased by fred alger management llc MarketBeat Tue, 16 Sep 2025 07:00:00 GMT
• polycythemia vera market: epidemiology, treatment landscape, and key players | incyte, novartis, pharmaessentia, aop orphan pharma... Barchart.com Tue, 16 Sep 2025 07:00:00 GMT
• inspire investing llc has $1.06 million stock holdings in protagonist therapeutics, inc. $ptgx MarketBeat Tue, 16 Sep 2025 07:00:00 GMT
• fred alger management llc makes new investment in protagonist therapeutics, inc. $ptgx MarketBeat Tue, 16 Sep 2025 04:18:15 GMT
• jobs data: is protagonist therapeutics inc stock good for income investors - july 2025 big picture & expert verified movement aler... khodrobank.com Tue, 16 Sep 2025 01:22:02 GMT
• protagonist announces icotrokinra application for approval in plaque psoriasis submitted to the european medicines agency Cincinnati Enquirer Tue, 16 Sep 2025 00:45:51 GMT
• protagonist announces icotrokinra application for approval in plaque psoriasis submitted to the european medicines agency The Des Moines Register Mon, 15 Sep 2025 23:21:22 GMT
• treasury yields: is protagonist therapeutics inc. a cyclical or defensive stock - 2025 dividend review & fast gain stock trading t... خودرو بانک Mon, 15 Sep 2025 15:41:25 GMT
• polycythemia vera market: epidemiology, treatment landscape, and key players | incyte, novartis, pharmaessentia, aop orphan pharma... Barchart.com Mon, 15 Sep 2025 15:38:00 GMT
• aug ideas: is protagonist therapeutics inc. stock forming a cup and handle - july 2025 reactions & verified entry point detection خودرو بانک Mon, 15 Sep 2025 14:32:21 GMT
• exploring high growth tech stocks in the us market september 2025 simplywall.st Mon, 15 Sep 2025 11:34:18 GMT
• stock recap: what is protagonist therapeutics inc. s revenue forecast - july 2025 technicals & growth focused entry reports خودرو بانک Mon, 15 Sep 2025 10:51:56 GMT
• protagonist therapeutics, inc. $ptgx stake raised by great lakes advisors llc MarketBeat Mon, 15 Sep 2025 10:10:07 GMT
• protagonist therapeutics (nasdaq:ptgx) upgraded at leerink partnrs MarketBeat Mon, 15 Sep 2025 09:55:03 GMT
• woodline partners lp buys 315,372 shares of protagonist therapeutics, inc. $ptgx MarketBeat Mon, 15 Sep 2025 09:24:09 GMT
• axiom investors llc de acquires new shares in protagonist therapeutics, inc. $ptgx MarketBeat Mon, 15 Sep 2025 09:22:07 GMT
• inspire investing llc raises stock position in protagonist therapeutics, inc. $ptgx MarketBeat Mon, 15 Sep 2025 09:21:01 GMT
• coppell advisory solutions llc acquires new shares in protagonist therapeutics, inc. $ptgx MarketBeat Mon, 15 Sep 2025 08:41:23 GMT
• Protagonist Therapeutics, Inc. $PTGX Shares Acquired by Great Lakes Advisors LLC MarketBeat Mon, 15 Sep 2025 07:00:00 GMT
• Protagonist Therapeutics: Promising Phase 2b Results and Strong Safety Profile Justify Buy Rating TipRanks Mon, 15 Sep 2025 07:00:00 GMT
• protagonist announces icotrokinra phase 2b anthem-uc trial data to be presented at the united european gastroenterology week berli... Bradenton Herald Mon, 15 Sep 2025 07:00:00 GMT
• wedbush maintains protagonist therapeutics(ptgx.us) with buy rating, maintains target price $70 富途牛牛 Mon, 15 Sep 2025 07:00:00 GMT
• protagonist therapeutics, inc. $ptgx stake raised by great lakes advisors llc MarketBeat Sun, 14 Sep 2025 19:47:54 GMT
• leerink partners initiates coverage on protagonist therapeutics (nasdaq:ptgx) MarketBeat Sun, 14 Sep 2025 12:23:11 GMT
• focus partners wealth raises holdings in protagonist therapeutics, inc. $ptgx MarketBeat Sun, 14 Sep 2025 10:16:53 GMT
• focus partners wealth purchases 9,540 shares of protagonist therapeutics, inc. $ptgx MarketBeat Sun, 14 Sep 2025 10:16:53 GMT
• axiom investors llc de invests $1.93 million in protagonist therapeutics, inc. $ptgx MarketBeat Sun, 14 Sep 2025 09:24:27 GMT
• wedbush maintains protagonist therapeutics(ptgx.us) with buy rating, maintains target price $70 富途牛牛 Sun, 14 Sep 2025 08:15:34 GMT
• empowered funds llc acquires shares of 102,532 protagonist therapeutics, inc. $ptgx MarketBeat Sun, 14 Sep 2025 08:13:14 GMT
• empowered funds llc takes $4.96 million position in protagonist therapeutics, inc. $ptgx MarketBeat Sun, 14 Sep 2025 08:13:14 GMT
• coppell advisory solutions llc invests $947,000 in protagonist therapeutics, inc. $ptgx MarketBeat Sun, 14 Sep 2025 07:54:36 GMT
• Protagonist Therapeutics (PTGX): A Fresh Valuation Perspective After European Filing for Oral Psoriasis Drug simplywall.st Sun, 14 Sep 2025 07:00:00 GMT
• coppell advisory solutions llc acquires new shares in protagonist therapeutics, inc. $ptgx MarketBeat Sun, 14 Sep 2025 07:00:00 GMT
• axiom investors llc de acquires new shares in protagonist therapeutics, inc. $ptgx MarketBeat Sun, 14 Sep 2025 07:00:00 GMT
• woodline partners lp buys 315,372 shares of protagonist therapeutics, inc. $ptgx MarketBeat Sun, 14 Sep 2025 07:00:00 GMT
• woodline partners lp purchases 315,372 shares of protagonist therapeutics, inc. $ptgx MarketBeat Sun, 14 Sep 2025 04:40:24 GMT
• fred alger management llc invests $362,000 in protagonist therapeutics, inc. $ptgx MarketBeat Sat, 13 Sep 2025 08:13:33 GMT
• 7,477 shares in protagonist therapeutics, inc. $ptgx acquired by fred alger management llc MarketBeat Sat, 13 Sep 2025 08:13:33 GMT
• protagonist therapeutics (nasdaq:ptgx) stock price down 8.7% - what's next? MarketBeat Sat, 13 Sep 2025 07:00:00 GMT
• state of wyoming sells 6,375 shares of protagonist therapeutics, inc. $ptgx MarketBeat Sat, 13 Sep 2025 07:00:00 GMT
• protagonist therapeutics, inc. $ptgx shares acquired by scientech research llc MarketBeat Sat, 13 Sep 2025 07:00:00 GMT
• Protagonist Therapeutics to Participate in Multiple Investment Bank Conferences in September 2025 The Des Moines Register Fri, 12 Sep 2025 22:33:50 GMT
• ptgx: leerink partners initiates coverage with outperform rating GuruFocus Fri, 12 Sep 2025 12:05:48 GMT
• great lakes advisors llc acquires 90,371 shares of protagonist therapeutics, inc. $ptgx MarketBeat Fri, 12 Sep 2025 10:30:12 GMT
• great lakes advisors llc has $7.37 million stock position in protagonist therapeutics, inc. $ptgx MarketBeat Fri, 12 Sep 2025 10:30:12 GMT
• great lakes advisors llc boosts stock position in protagonist therapeutics, inc. $ptgx MarketBeat Fri, 12 Sep 2025 10:30:12 GMT
• This Protagonist Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Friday Benzinga Fri, 12 Sep 2025 07:00:00 GMT
• leerink partners initiates protagonist therapeutics at outperform with $73 price target MarketScreener Fri, 12 Sep 2025 07:00:00 GMT
• protagonist therapeutics: buy rating backed by promising drug assets and strategic partnerships TipRanks Fri, 12 Sep 2025 07:00:00 GMT
• protagonist therapeutics initiated with an outperform at leerink TipRanks Fri, 12 Sep 2025 07:00:00 GMT
• protagonist therapeutics (nasdaq:ptgx) shares down 8.7% - time to sell? MarketBeat Fri, 12 Sep 2025 07:00:00 GMT
• scientech research llc buys 6,217 shares of protagonist therapeutics, inc. $ptgx MarketBeat Fri, 12 Sep 2025 07:00:00 GMT
• rusfertide receives breakthrough therapy designation for treatment of erythrocytosis in patients with polycythemia vera Lansing State Journal Fri, 12 Sep 2025 06:24:44 GMT
• woodline partners lp purchases 315,372 shares of protagonist therapeutics, inc. $ptgx MarketBeat Thu, 11 Sep 2025 11:10:46 GMT
• woodline partners lp grows holdings in protagonist therapeutics, inc. $ptgx MarketBeat Thu, 11 Sep 2025 11:10:46 GMT
• axiom investors llc de invests $1.93 million in protagonist therapeutics, inc. $ptgx MarketBeat Thu, 11 Sep 2025 10:38:10 GMT
• axiom investors llc de takes $1.93 million position in protagonist therapeutics, inc. $ptgx MarketBeat Thu, 11 Sep 2025 10:38:10 GMT
• 39,969 shares in protagonist therapeutics, inc. $ptgx bought by axiom investors llc de MarketBeat Thu, 11 Sep 2025 10:38:10 GMT
• coppell advisory solutions llc takes $947,000 position in protagonist therapeutics, inc. $ptgx MarketBeat Thu, 11 Sep 2025 10:17:49 GMT
• coppell advisory solutions llc makes new $947,000 investment in protagonist therapeutics, inc. $ptgx MarketBeat Thu, 11 Sep 2025 10:17:49 GMT
• 20,765 shares in protagonist therapeutics, inc. $ptgx bought by coppell advisory solutions llc MarketBeat Thu, 11 Sep 2025 10:17:49 GMT
• H.C. Wainwright Sticks to Its Buy Rating for Protagonist Therapeutics (PTGX) The Globe and Mail Thu, 11 Sep 2025 07:00:00 GMT
• protagonist announces icotrokinra application for approval in plaque psoriasis submitted to the european medicines agency Akron Beacon Journal Thu, 11 Sep 2025 07:00:00 GMT
• first oral il-23 blocker shows superior results: protagonist's icotrokinra aims to transform psoriasis care Stock Titan Thu, 11 Sep 2025 07:00:00 GMT
• adage capital partners gp l.l.c. invests $16.61 million in protagonist therapeutics, inc. $ptgx MarketBeat Thu, 11 Sep 2025 07:00:00 GMT
• protagonist therapeutics announces icotrokinra application submitted to ema TipRanks Thu, 11 Sep 2025 07:00:00 GMT
• state of wyoming has $70,000 stake in protagonist therapeutics, inc. $ptgx MarketBeat Thu, 11 Sep 2025 07:00:00 GMT
• adage capital partners gp l.l.c. acquires shares of 343,504 protagonist therapeutics, inc. $ptgx MarketBeat Thu, 11 Sep 2025 02:00:23 GMT
• protagonist therapeutics (nasdaq:ptgx) shares down 8.7% - here's why MarketBeat Wed, 10 Sep 2025 19:22:19 GMT
• protagonist therapeutics (nasdaq:ptgx) trading down 8.7% - what's next? MarketBeat Wed, 10 Sep 2025 19:22:19 GMT
• scientech research llc buys 6,217 shares of protagonist therapeutics, inc. $ptgx MarketBeat Wed, 10 Sep 2025 13:34:15 GMT
• scientech research llc has $884,000 stake in protagonist therapeutics, inc. $ptgx MarketBeat Wed, 10 Sep 2025 13:34:15 GMT
• scientech research llc grows position in protagonist therapeutics, inc. $ptgx MarketBeat Wed, 10 Sep 2025 13:34:15 GMT
• adage capital partners gp l.l.c. acquires shares of 343,504 protagonist therapeutics, inc. $ptgx MarketBeat Wed, 10 Sep 2025 08:33:20 GMT
• state of wyoming sells 6,375 shares of protagonist therapeutics, inc. $ptgx MarketBeat Wed, 10 Sep 2025 07:30:19 GMT
• state of wyoming reduces position in protagonist therapeutics, inc. $ptgx MarketBeat Wed, 10 Sep 2025 07:30:19 GMT
• new vernon capital holdings ii llc purchases 345,034 shares of protagonist therapeutics, inc. $ptgx MarketBeat Wed, 10 Sep 2025 07:00:00 GMT
• protagonist therapeutics’ pn-881 study: a closer look at market implications MSN Wed, 10 Sep 2025 06:11:26 GMT
• 175,184 shares in protagonist therapeutics, inc. $ptgx purchased by checkpoint capital l.p. MarketBeat Wed, 10 Sep 2025 05:24:11 GMT
• new vernon capital holdings ii llc buys 345,034 shares of protagonist therapeutics, inc. $ptgx MarketBeat Wed, 10 Sep 2025 04:35:30 GMT
• polycythemia vera market to experience notable growth in forecast span by 2034, delveinsight predicts | novartis, protagonist ther... The Globe and Mail Tue, 09 Sep 2025 16:04:00 GMT
• checkpoint capital l.p. invests $8.47 million in protagonist therapeutics, inc. $ptgx MarketBeat Tue, 09 Sep 2025 08:23:44 GMT
• 175,184 shares in protagonist therapeutics, inc. $ptgx purchased by checkpoint capital l.p. MarketBeat Tue, 09 Sep 2025 07:00:00 GMT
• efg asset management north america corp. invests $3.44 million in protagonist therapeutics, inc. $ptgx MarketBeat Tue, 09 Sep 2025 07:00:00 GMT
• protagonist therapeutics to participate in multiple investment bank conferences in september 2025 Gadsden Times Tue, 09 Sep 2025 06:31:30 GMT
• protagonist therapeutics, inc. $ptgx is bvf inc. il's 6th largest position MarketBeat Tue, 09 Sep 2025 04:31:44 GMT
• will protagonist therapeutics inc. hold gains into close - insider buying & risk controlled stock alerts beatles.ru Mon, 08 Sep 2025 22:38:29 GMT
• protagonist reports second quarter 2025 financial results and provides corporate update Gadsden Times Mon, 08 Sep 2025 12:38:02 GMT
• those who invested in protagonist therapeutics (nasdaq:ptgx) three years ago are up 573% 富途牛牛 Mon, 08 Sep 2025 10:27:11 GMT
• Protagonist Therapeutics, Inc. $PTGX is BVF Inc. IL's 6th Largest Position MarketBeat Mon, 08 Sep 2025 07:00:00 GMT
• protagonist therapeutics, inc. $ptgx shares purchased by 683 capital management llc MarketBeat Mon, 08 Sep 2025 03:11:15 GMT
• will protagonist therapeutics inc. benefit from geopolitical trends - 2025 technical patterns & long hold capital preservation pla... beatles.ru Sun, 07 Sep 2025 23:33:32 GMT
• protagonist announces submission of nda for first icotrokinra u.s. fda approval aiming to revolutionize treatment paradigm for adu... aberdeennews.com Sun, 07 Sep 2025 12:48:15 GMT
• protagonist therapeutics, inc. $ptgx shares bought by new vernon capital holdings ii llc MarketBeat Sun, 07 Sep 2025 12:14:53 GMT
• Protagonist Therapeutics’ PN-881 Study: A Closer Look at Market Implications TipRanks Sun, 07 Sep 2025 07:00:00 GMT
• protagonist therapeutics, inc. $ptgx shares purchased by 683 capital management llc MarketBeat Sun, 07 Sep 2025 07:00:00 GMT
• adar1 capital management llc trims stake in protagonist therapeutics, inc. $ptgx MarketBeat Sun, 07 Sep 2025 07:00:00 GMT
• hightower advisors llc makes new investment in protagonist therapeutics, inc. $ptgx MarketBeat Sat, 06 Sep 2025 16:07:30 GMT
• landscape capital management l.l.c. invests $375,000 in protagonist therapeutics, inc. $ptgx MarketBeat Sat, 06 Sep 2025 16:07:30 GMT
• applying wyckoff theory to protagonist therapeutics inc. stock - 2025 biggest moves & safe swing trade setups Newser Sat, 06 Sep 2025 08:31:56 GMT
• is protagonist therapeutics inc. a cyclical or defensive stock - 2025 risk factors & real-time sentiment analysis خودرو بانک Sat, 06 Sep 2025 07:47:28 GMT
• what is protagonist therapeutics inc. s revenue forecast - july 2025 short interest & high return trade guides خودرو بانک Sat, 06 Sep 2025 07:35:34 GMT
• 149,908 shares in protagonist therapeutics, inc. $ptgx purchased by panagora asset management inc. MarketBeat Sat, 06 Sep 2025 07:00:00 GMT
• magnetar financial llc invests $539,000 in protagonist therapeutics, inc. $ptgx MarketBeat Sat, 06 Sep 2025 07:00:00 GMT
• trexquant investment lp has $5.03 million holdings in protagonist therapeutics, inc. $ptgx MarketBeat Sat, 06 Sep 2025 07:00:00 GMT
• aug levels: is protagonist therapeutics inc. in a bullish channel - earnings recap report & weekly high return stock opportunities... classian.co.kr Fri, 05 Sep 2025 20:03:09 GMT
• institutional scanner results for protagonist therapeutics inc. - july 2025 outlook & community supported trade ideas Newser Fri, 05 Sep 2025 19:06:06 GMT
• live market analysis of protagonist therapeutics inc. - bull run & fast momentum entry tips Newser Fri, 05 Sep 2025 19:05:15 GMT
• what’s the recovery path for long term holders of protagonist therapeutics inc. - july 2025 weekly recap & high accuracy investmen... Newser Fri, 05 Sep 2025 18:43:20 GMT
• is protagonist therapeutics inc. a cyclical or defensive stock - treasury yields & stock portfolio risk management خودرو بانک Fri, 05 Sep 2025 18:37:21 GMT
• will protagonist therapeutics inc. benefit from geopolitical trends - market sentiment report & real-time volume spike alerts خودرو بانک Fri, 05 Sep 2025 13:16:48 GMT
• applying wyckoff theory to protagonist therapeutics inc. stock - july 2025 analyst calls & daily oversold stock bounce ideas Newser Fri, 05 Sep 2025 11:15:36 GMT
• can protagonist therapeutics inc. expand into new markets - 2025 fundamental recap & reliable price breakout signals خودرو بانک Fri, 05 Sep 2025 08:17:12 GMT
• is protagonist therapeutics inc. affected by consumer sentiment - 2025 volume leaders & ai driven stock reports خودرو بانک Fri, 05 Sep 2025 07:33:36 GMT
• rafferty asset management llc has $2.14 million position in protagonist therapeutics, inc. $ptgx MarketBeat Fri, 05 Sep 2025 07:00:00 GMT
• driehaus capital management llc has $11.37 million holdings in protagonist therapeutics, inc. $ptgx MarketBeat Fri, 05 Sep 2025 07:00:00 GMT
• custom watchlist performance reports with protagonist therapeutics inc. - july 2025 review & reliable momentum entry alerts Newser Fri, 05 Sep 2025 04:50:17 GMT
• can volume confirm reversal in protagonist therapeutics inc. - 2025 investor takeaways & risk managed trade strategies Newser Fri, 05 Sep 2025 04:36:01 GMT
• will protagonist therapeutics inc. benefit from rate cuts - cpi data & technical pattern recognition alerts خودرو بانک Fri, 05 Sep 2025 03:49:20 GMT
• is protagonist therapeutics inc. vulnerable to short sellers - 2025 endofyear setup & entry point confirmation signals خودرو بانک Fri, 05 Sep 2025 03:10:47 GMT
• is protagonist therapeutics inc. in a bullish channel - 2025 support & resistance & consistent profit trading strategies خودرو بانک Fri, 05 Sep 2025 00:28:14 GMT
• how is protagonist therapeutics inc. managing supply chain issues - 2025 year in review & verified momentum stock ideas خودرو بانک Thu, 04 Sep 2025 23:44:28 GMT
• using ichimoku cloud for protagonist therapeutics inc. technicals - market risk report & daily stock momentum reports Newser Thu, 04 Sep 2025 23:22:03 GMT
Protagonist Therapeutics, Inc(NASDAQ:PTGX) 
Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address unmet medical needs. It is developing PTG-300, an injectable hepcidin mimetic that is in Phase II clinical trial for the treatment of patients with polycythem...
Website: http://www.protagonist-inc.com
Founded: 2006
Full Time Employees: 76
Sector: Healthcare
Industry: Biotechnology